Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENELUX CorpGNLX · Entity 1116 | General Counsel | May 12, 2025 | May 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENELUX Corp
Report date May 12, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,621 |
Reported balance
After 2025-05-12 transaction · row 1
1 source rowRow 1 · 2025-05-12 · Sale · Disposed 4,475 · Balance 47,621 F1: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2025 Filed May 13, 2025 21:05 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 4,475 | $2.92 | $13,067.00 |
DisclosureSEC source: 0001415889-25-012809 · form4-05132025_050537.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,621 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. Read SEC document |
| March 14, 2025 Filed Apr 17, 2025 20:55 UTC | GENELUX Corp GNLX · Entity 1116 | GrantCommon Stock | 10,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-010878 · form4-04172025_080416.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,096 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025. Read SEC document |
| December 18, 2024 Filed Dec 21, 2024 01:48 UTC | GENELUX Corp GNLX · Entity 1116 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001415889-24-030006 · form4-12212024_011207.xml · derivative · entry 2 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-12-17 F2 · derivative.exercise_date: 25% of the shares vest on August 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| December 18, 2024 Filed Dec 21, 2024 01:48 UTC | GENELUX Corp GNLX · Entity 1116 | GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-030006 · form4-12212024_011207.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,388 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 25% of the RSUs vest on August 1, 2025, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. Read SEC document |
| June 24, 2024 Filed Jul 8, 2024 20:30 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 5,496 | $2.12 | $11,651.52 |
DisclosureSEC source: 0001415889-24-019342 · form4-07082024_040707.xml · nonDerivative · entry 3 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,388 F3 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of the RSUs. F4 · balance_after: Includes 2,106 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2024. Read SEC document |
| May 29, 2024 Filed Jun 8, 2024 01:40 UTC | GENELUX Corp GNLX · Entity 1116 | PurchaseCommon Stock Warrant (Right to Buy) · Derivative | 10,000 | Not disclosed Strike: $5.25 | Not disclosed |
DisclosureSEC source: 0001415889-24-016098 · form4-06072024_090603.xml · derivative · entry 2 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-29 F1 · price: The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00. Read SEC document |
| May 29, 2024 Filed Jun 8, 2024 01:40 UTC | GENELUX Corp GNLX · Entity 1116 | PurchaseCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-016098 · form4-06072024_090603.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,572 F1 · price: The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00. Read SEC document |
| March 14, 2024 Filed Jul 8, 2024 20:30 UTC | GENELUX Corp GNLX · Entity 1116 | GrantCommon Stock | 9,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019342 · form4-07082024_040707.xml · nonDerivative · entry 2 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,778 F2 · kind: Represents RSUs that are fully vested as of March 14, 2024. Read SEC document |
| February 19, 2024 Filed Jul 8, 2024 20:30 UTC | GENELUX Corp GNLX · Entity 1116 | GrantCommon Stock | 2,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019342 · form4-07082024_040707.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,508 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 20:30 UTC | GENELUX Corp GNLX · Entity 1116 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001209191-23-050274 · doc4.xml · derivative · entry 3 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 10,000 shares Expires 2031-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares shall vest on October 4, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 20:30 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 10,000 | $30.00 | $300,000.00 |
DisclosureSEC source: 0001209191-23-050274 · doc4.xml · nonDerivative · entry 2 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 20:30 UTC | GENELUX Corp GNLX · Entity 1116 | Exercise / conversionCommon Stock | 10,000 | $6.00 | $60,000.00 |
DisclosureSEC source: 0001209191-23-050274 · doc4.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2023 Filed Sep 12, 2023 20:26 UTC | GENELUX Corp GNLX · Entity 1116 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001209191-23-049105 · doc4.xml · derivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-09-10 F1 · derivative.exercise_date: 25% of the shares shall vest on September 11, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 20:16 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 328 | $23.73 | $7,783.44 |
DisclosureSEC source: 0001209191-23-046884 · doc4.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572 F1 · shares: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $23.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| February 17, 2023 Filed May 2, 2023 20:25 UTC | GENELUX Corp GNLX · Entity 1116 | GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026497 · doc4.xml · nonDerivative · entry 1 Ryder Sean · CIK 0001937485 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will be fully vested on July 25, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.